byMcGill UniversityLab work. Credit: The Neuro (Montreal Neurological Institute-Hospital)Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McG
byMcGill UniversityLab work. Credit: The Neuro (Montreal Neurological Institute-Hospital)Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McG
by India EdwardsThe U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.In a n
by India EdwardsThe U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.In a n
FDA expands approval of Vtama to include atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the
FDA expands approval of Vtama to include atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the
by Elana GotkineFor patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a studypublished&nbs
by Elana GotkineFor patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a studypublished&nbs
byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainAnxiety is extremely common among adults receiving cancer care, with as many as one out of every four patients meeting the clinical
byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainAnxiety is extremely common among adults receiving cancer care, with as many as one out of every four patients meeting the clinical